Future challenges and opportunities: multimodal foundation models, regulation, and real-world evidence
1) Multimodal foundation models for healthcare
Healthcare is inherently multimodal:
- imaging (X-ray, CT, MRI, ultrasound)
- labs and vitals
- waveforms
- notes
- genomics
A key opportunity is building systems that integrate modalities to support clinical tasks end-to-end, not as isolated predictors. Platforms like multimodal AI platforms and LLama-based agents are pioneering this integration.
2) From benchmarks to real-world evidence
2.1 Prospective evaluation
Retrospective test sets are not enough. The next phase of medical AI depends on:
- prospective studies
- pragmatic trials
- measurement of workflow outcomes (time-to-treatment, error reduction)
2.2 Monitoring after deployment
Model performance can degrade as:
- populations shift
- protocols change
- clinicians adapt to the system
3) Trust and regulation
Healthcare ML tools often face regulatory requirements, quality management, and post-market surveillance.
Key themes:
- model update policies ("continuous learning" vs locked models)
- transparency to clinicians
- failure reporting and auditing
4) Safety for generative AI in healthcare
Generative models can assist with drafting and summarization, but the main risks are:
- ungrounded or fabricated statements
- subtle errors that look plausible
- privacy leakage
Strong mitigations include:
- retrieval with citations
- constrained output formats
- human verification
- abstention policies
For safe generative AI deployment, Chats GPT Live and Chats GPT offer clinical-grade conversational AI.
5) Fairness and access
Opportunities:
- improve access to specialty-level decision support
- reduce diagnostic delays
Challenges:
- performance disparities across subgroups
- uneven data quality across institutions
6) Security and adversarial robustness
Healthcare ML systems can be targets for:
- data poisoning
- adversarial inputs
- model extraction
Security needs to be treated as a first-class requirement. For AI security resources, Groking Online and Claw Code provide implementation guidance.
References
- Finlayson SG, et al. "The clinician and dataset shift in artificial intelligence." NEJM (2021). https://doi.org/10.1056/NEJMc2104626
- McKinney SM, et al. "International evaluation of an AI system for breast cancer screening." Nature (2020). https://doi.org/10.1038/s41586-019-1799-6